Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Battling Parkinson's and Alzheimer's: The Neuroprotective Power of Carnosic Acid.

Journal of biochemical and molecular toxicology·2026

Same author

NLRP3 inflammasome: A key player in cardiac fibroblast to myofibroblast transition.

Pathology, research and practice·2026

Same author

Isolation, antimicrobial evaluation, and in silico docking of spinasterol from Impatiens rothii Hook. f. tuber extract.

Tropical medicine and health·2026

Same author

Aging-driven reprogramming of CD34⁺ hematopoietic stem cells in leukemogenesis: Mechanisms and therapeutic implications.

Mechanisms of ageing and development·2026

Same author

Withaferin A in breast cancer therapy: multi-targeted modulation of redox homeostasis, autophagy, and apoptosis.

Journal of Asian natural products research·2026

Same author

Decoding the Role of Nutrition and Foods in Augmenting Athletes Performance: A Review.

Current drug research reviews·2026

Same journal

A follow-up cohort study on secondary findings in cancer predisposition genes from 20,205 Chinese individuals.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Chemometric profiling reveals selective circulating bile acid remodeling in Alzheimer's disease.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Serum sialic acid is independently associated with cerebrovascular atherosclerotic stenosis severity and total vascular burden: A retrospective cohort study.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Measurement of low-density lipoprotein cholesterol and other circulating lipids in Brazil: a systematic literature review.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Reference intervals for venous blood gas measurement in a healthy Chinese population.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Multiplex methylation marker analysis for ctDNA detection in liquid biopsies from anal cancer patients: an HPV-independent approach.

Clinica chimica acta; international journal of clinical chemistry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Beta-2 microglobulin in lymphoma.

Gaurav Gupta¹, Muhammad Afzal², Ahsas Goyal³

¹Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.

Clinica Chimica Acta; International Journal of Clinical Chemistry

|June 9, 2025

Summary

This summary is machine-generated.

Beta-2-microglobulin (β2M) is a key biomarker in lymphomas, aiding diagnosis and prognosis. Targeting β2M pathways shows promise for novel lymphoma therapies, though standardization and validation are needed.

Keywords:

Beta-2 Microglobulin Biomarkers Immune surveillance Lymphoma MHC Class I Prognosis

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Related Experiment Videos

Last Updated: Jun 12, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Area of Science:

Hematology
Immunology
Biochemistry

Background:

Lymphomas are cancers of lymphocytes with significant heterogeneity.
Beta-2-microglobulin (β2M) is crucial for MHC I structure and serves as a vital biomarker.
Elevated β2M levels are linked to lymphoma burden, poor prognosis, and CNS involvement.

Purpose of the Study:

To review the diagnostic and prognostic significance of β2M in lymphomas.
To explore the mechanistic roles of β2M in lymphoma proliferation and immune evasion.
To discuss emerging therapeutic strategies targeting β2M pathways and future research directions.

Main Methods:

Literature review of β2M's role in lymphoma diagnosis and prognosis.
Analysis of β2M's mechanistic functions in T-cell antigen presentation and signaling pathways.
Evaluation of preclinical and emerging therapeutic approaches targeting β2M.

Main Results:

Serum and CSF β2M levels correlate with lymphoma stage, burden, and survival outcomes.
β2M stabilizes MHC I, facilitates T-cell response, and activates pro-tumorigenic pathways when shed.
Preclinical studies show combined anti-β2M therapy and proteasome inhibitors enhance cytotoxicity.

Conclusions:

β2M is a significant biomarker for lymphoma diagnosis, prognosis, and therapeutic targeting.
Mechanotherapy and advanced culture platforms offer new avenues for modulating β2M signaling.
Standardization of assays and prospective validation are critical for clinical implementation.